InSyBio

📢InSyBio Suite Version 3.2 is released democratizing #singlecell #RNAsequencing analysis by allowing optimized elaborate analytics to non-bioinformatics experts through its web interface. The new version enables: -optimized analysis from raw data simplifying the process and ability to be run by non-bioinformatics experts. -Efficient #integration of multiple scRNAseq datasets, removing efficiently the technical biases and maintaining biological variability. -#Celldeconvolution of bulk transcriptomics and proteomics data using scRNAseq data. -Discovery and documentation of cell-cell communication patterns using CellChat workflow. -Discovery of single-cell trajectories and RNA-velocity patterns using scVelo workflow -Custom figure preparation and documented bioinformatics analysis integrated with additional tools of InSyBio Suite for #biomarkerdiscovery, #network and #AI / #machinelearning analysis. Read more details about these at: https://lnkd.in/enqnEUsV and request a free trial at: https://lnkd.in/ePZu9x6K #bioinformatics #webplatform #mapping #cellclustering #cellannotation #celltrajectories #cellcellcommunication

We are #hiring! We are seeking a talented junior software engineer with a Bachelor’s Diploma in Computer Engineering or any related diploma to work at our premises in Patras Science Park ( Επιστημονικό Πάρκο Πατρών), in Patras, Greece. The hired person will join our interdisciplinary team and work on the development and support of back-end functionalities of our biomedical data analysis platform, InSyBio Suite. The person who will be hired should participate in the Marie Skłodowska-Curie Actions (MSCA) grant OsteoNet (https://lnkd.in/e_g9wCqh) and conduct secondments in Italy & Belgium at the academic partners of the consortium. See details for this position at: https://lnkd.in/eVHGAGvP and send us your CV to consider you for this post at: careers@insybio.com #hiringnow #dataanalysis #juniorengineer #bioinformatics #machinelearning

⚡️⚡️⚡️⚡️⚡️ The Super-Entrepreneurship Monday Post ⚡️⚡️⚡️⚡️⚡️ ✅ Tip of the week Why we should invest more in the convergence of AI and biotech. 🧬💻 By marrying AI's predictive prowess with biotech's life-altering innovations, we're on the cusp of unlocking solutions to some of humanity's most pressing challenges. 🌍❤️ This journey into AI-driven biotechnological innovation will foster a healthier, smarter, and more sustainable world for generations to come. 🌱🔬 👉 Want to know more? Read my latest article: https://lnkd.in/ehxiw2Q6 ✅ Quote of the week "Biotechnology and AI have the potential to resurrect the dreams of the past as well as create hopes for the future. As we blend these technologies, we are essentially reprogramming the world for a better tomorrow." - Ray Kurzweil, Inventor and Futurist ✅ Question of the week If you are working in the field of medicine or healthcare, which crazy idea leveraging AI could lead to a real breakthrough? Build the world you love. Fabrice 🙏🏽 Like it? Then, please share it with someone who needs to see it. 🙏🏽 #fabricetesta #AI #Biotech #Innovation #HealthTech #InvestmentJourney 🔥 Some useful links in the comments here below ⬇️

💡Single-cell technologies are here to stay. Among other challenges, the single-cell data analysis is far from being standardized with many open issues, such as handling data scarcity, identifying cells and cell communication patterns, retrieving cell trajectories and using single-cell data to deconvolve bulk omics data, not yet been fully elucidated. This great review suggests comprehensive best practices for data analysis and experimental protocol design for single-cell applications across different omics modalities. https://lnkd.in/g7TEw432 #research #singlecell #singlecellanalysis #scRNAseq

It was our pleasure to be presented today at the Loyal VC Portfolio Showcase online event. Great companies and teams with innovative solutions for diverse industries were presented to an audience of investors across the world. Contact us to get more details for our current financial round. #fundraising #startups #angelinvesting #venturecapital #investmentopportunity

Congratulations to InSyBio for winning "Best Start-Up Initiative in 2023" at the CPHI Pharma Awards! InSyBio's groundbreaking work in targeted biomarker discovery and highly accurate predictive analytics impressed judges, offering a revolutionary impact on medical, clinical trials, and food/nutrition sectors. For more Loyal portfolio news, visit: https://lnkd.in/gimekqR6 Labros Digonis Konstantinos Theofilatos #venturecapital #angelinvesting #biomarkers #tech #ai #startupsuccess

The Industrial Systems Institute / Research Centre ATHENA hosted on November 3, 2023 the final event of project VIRTUOUSH2020 at the premises of the "Athena" Research and Innovation Center in Athens. The event provided a good opportunity to present the final outcomes of the Virtuous project as well as network with SMEs and other projects in the domain of food. The Virtuous project has developed an integrated computational framework with the ability to screen food according to their components and make a classification of their expected taste, thus functioning as a “virtual tongue”. The platform has a potential for being used as a taste predictor in the food industry, precision agriculture, and as a link to neuroscience for taste determination. The platform is available at https://lnkd.in/dfkRhkJC while full information on the project can be found at https://virtuoush2020.com/ Invited talks in the event were given by the Università degli Studi di Firenze on the contribution of sensory science to food perception and preference, VINHOOD on taste profiling, Fitly on the future of personalized nutrition, ATHENA Research Center on GRE Taste project, and the University of the Aegean on food waste.

"InSyBio impressed the judges reviewing the brand-new Start-Up Initiative category for its ability to revolutionize the medical field, clinical trials and food/nutrition industries through its targeted biomarker discovery. They have developed highly accurate predictive analytics enabling personalization of tests for drugs, nutraceuticals and nutrition products. Its solutions provide the R&D departments of Pharma, Research Institutes and Food/Nutrition companies with the means both analytically and computationally to meet their challenging research and innovation goals.", statement at the CPHI awards 2023 press release (https://lnkd.in/eyH3VexX). InSyBio was recognized as the best Start-Up Initiative in 2023 at CPHI Pharma Awards! CPHI is the biggest worldwide exhibition and event for the Pharma Industry and is organised annually and the CPHI Pharma Awards recognise progress and innovation across the pharma supply chain. Read more details about our announcement for winning this award at: https://lnkd.in/eWduETpt At InSyBio we are personalizing pharma and nutrition products using #AI with benefits for both the companies and the consumers/patients. #CPHI #innovation #CPHIPharmaAwards #precisionmedicine #personalizednutrition #technology #pharma #cphibarcelona #startup

We are delighted to participate in this great network of researchers and look forward to putting our predictive analytics technology in service of predicting outcomes and attempting to personalize regenerative bone engineering and bioinspired materials using Quantum Magnetic Resonance data. During this kick-off meeting, Lampros Androutsos representing InSyBio provided a summary of our technology, while we also had the chance to meet the rest of the consortium in person providing them with a technology transfer hands-on workshop on the use of machine learning for the analysis of biomedical data.

🎉It is our great honour to bestow us with the Startup Pharma award at this year's #CPHIPharmaAwards! It is great to be recognised for the efforts and the challenges we overcame in the journey to create an AI-empowered analysis platform which we anticipate to save many patients' lives by providing them with the drug or nutraceutical products they need on time. We are expecting Pharma and Nutraceutical companies at our booth (3QS75) at the startup market in Hall 3 tomorrow to form synergies for the development of personalized treatment and nutrition products. We are also expecting you all at the Pitch Session at 11:30 am on Day 2 – 25th October being held on the stage of the startup market. At InSyBio we are personalizing pharma and nutrition products using #AI with benefits for both the companies and the consumers/patients. #CPHI #innovation